U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07777406) titled 'Real-life Study on the Use of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Relapsed/Refractory Multiple Myeloma' on July 10.
Brief Summary: A multicenter, non-interventional, observational, retrospective and prospective pharmacological study aimed at evaluating the use of allogeneic hematopoietic stem cell transplantation in patients with relapsed/refractory multiple myeloma.
Study Start Date: March 24
Study Type: OBSERVATIONAL
Condition:
Plasma Cell Neoplasms
Recruitment Status: RECRUITING
Sponsor: Universita degli Studi 'G. d'Annunzio' Chieti e Pescara
Information provided by (Responsible Party): Carm...